Nasal cavity washing composition
Patent Information
- Application Number
- MYPI2025001241
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-08-23
- Filing Date
- 2023-07-27
- Publication Date
- 2024-02-23
AI Technical Summary
Nasal cavity cleaning compositions often irritate the nasal mucosa due to preservatives, and existing formulations do not adequately address this issue while providing effective antibacterial properties.
A nasal cavity cleaning composition containing a preservative, sodium bicarbonate, and a mint fragrance, specifically using quaternary ammonium salts or paraoxybenzoic acid esters, with peppermint oil to alleviate irritation, and optionally including a nonionic surfactant.
The composition effectively reduces irritation to the nasal mucosa while maintaining antibacterial efficacy, as demonstrated by significant relief in irritation scores from user evaluations.
Abstract
Description
Nasal wash composition
[0001] The present invention relates to a nasal rinse composition that contains a preservative and has reduced irritation to the nasal mucosa.
[0002] The nasal mucosa is an epithelial tissue that is directly exposed to the outside world and sensitively responds to external stimuli. It is known that adhesion of foreign substances such as pollen, microorganisms, and house dust to the nasal mucosa can cause unbearable discomfort and lead to the development of various diseases, including allergies and infectious diseases. Removing foreign substances attached to the mucosa using a nasal cleansing composition is effective in preventing or ameliorating such nasal mucosa symptoms. Furthermore, unlike other epithelial tissues such as skin, the nasal mucosa is not covered by an epidermis, and therefore, nasal cleansing compositions must be formulated with consideration given to irritation to the nasal mucosa.
[0003] Nasal irrigation compositions are required to have antiseptic properties because they may be used when going out or may be used repeatedly. Accordingly, various formulations of nasal irrigation compositions containing antiseptics such as benzalkonium chloride have been reported (see, for example, Patent Document 1).
[0004] In addition, in view of the irritating properties of preservatives, a formulation that includes a nonionic surfactant in a nasal cleansing composition containing a parahydroxybenzoic acid ester has been proposed as a formulation that can alleviate the irritation caused by preservatives (see, for example, Patent Document 2).
[0005] JP 11-92368 A JP 2022-094512 A
[0006] The present inventors have developed a formulation for adding sodium bicarbonate to a nasal cleansing composition containing a preservative such as a quaternary ammonium salt in order to enhance the antibacterial effect of the composition. If it becomes possible to design a formulation based on this formulation that can further reduce irritation to the nasal mucosa, the usefulness of the nasal cleansing composition will be further enhanced.
[0007] Therefore, an object of the present invention is to provide a formulation for a nasal irrigation composition containing a preservative and sodium bicarbonate that reduces irritation to the nasal mucosa.
[0008] The present inventors have conducted extensive research to solve the above problems and have found that adding a mint-based flavor to a nasal cleansing composition containing a preservative and sodium bicarbonate can effectively reduce irritation to the nasal mucosa. Based on this finding, the present invention was completed through further research.
[0009] That is, the present invention provides the following aspects of the invention. Item 1. A nasal cleansing composition containing (A) a preservative, (B) sodium bicarbonate, and (C) a mint-based flavor. Item 2. The nasal cleansing composition of Item 1, in which component (A) is a quaternary ammonium and / or a parahydroxybenzoate ester. Item 3. The nasal cleansing composition of Item 1 or 2, in which component (C) contains peppermint oil. Item 4. The nasal cleansing composition of any of Items 1 to 3, in which the content of component (C) is 0.005 to 0.3 wt %. Item 5. The nasal cleansing composition of any of Items 1 to 4, in which component (C) is contained in an amount of 0.005 to 1 part by weight per part by weight of component (A). Item 6. The nasal cleansing composition of any of Items 1 to 5, further containing (D) a nonionic surfactant.
[0010] According to the present invention, a nasal cleansing composition that is less irritating to the nasal mucosa is provided.
[0011] The nasal cleansing composition of the present invention is characterized by containing (A) a preservative (hereinafter also referred to as "component (A)"), (B) sodium bicarbonate (hereinafter also referred to as "component (B)"), and (C) a mint-based flavoring (hereinafter also referred to as "component (C)"). The nasal cleansing composition of the present invention will be described in detail below.
[0012] (A) Preservative The nasal cleansing composition of the present invention contains a preservative as component (A). Specific preservatives used in the present invention are not particularly limited, and examples thereof include quaternary ammonium salts, parahydroxybenzoates, chlorobutanol, chlorhexidine gluconate, chlorhexidine acetate, dehydroacetic acid or its salts, benzyl alcohol, zinc chloride, parachlormetaxylenol, chlorcresol, phenethyl alcohol, polydronium chloride, thimerosal, and dibutylhydroxytoluene.
[0013] Specific examples of quaternary ammonium salts include benzalkonium chloride, cetylpyridinium chloride, benzethonium chloride, dequalinium chloride, alkyldimethylammonium chloride, alkyltrimethylammonium chloride, methylbenzethonium chloride, lauroylcholaminoformylmethylpyridinium chloride, etc., and more preferably benzalkonium chloride. These quaternary ammonium salts may be in the form of solvates such as hydrates.
[0014] The parahydroxybenzoate ester is an alkyl ester or benzyl ester of parahydroxybenzoic acid. Examples of the alkyl group in the alkyl ester of parahydroxybenzoic acid include linear or branched alkyl groups having 1 to 5 carbon atoms. Specific examples of the parahydroxybenzoate ester include methyl parahydroxybenzoate, ethyl parahydroxybenzoate, propyl parahydroxybenzoate, isopropyl parahydroxybenzoate, butyl parahydroxybenzoate, isobutyl parahydroxybenzoate, and benzyl parahydroxybenzoate, with methyl parahydroxybenzoate being preferred.
[0015] These preservatives may be used alone or in combination of two or more.
[0016] Among these preservatives, from the viewpoint of more effectively alleviating irritation to the nasal mucosa, preferred are quaternary ammonium salts and parahydroxybenzoic acid esters, more preferred are quaternary ammonium salts, and even more preferred is benzalkonium chloride.
[0017] The content of component (A) in the nasal cleansing composition of the present invention can be appropriately set depending on the type of preservative used and / or the antibacterial activity to be imparted, and / or whether or not the nasal cleansing composition needs to be diluted when used, the dilution ratio, etc. The content of component (A) in the nasal cleansing composition of the present invention is, for example, 0.0001 to 0.6% by weight in total, and from the viewpoint of further enhancing the effect of alleviating irritation to the nasal mucosa, is preferably 0.0001 to 0.3% by weight, more preferably 0.0001 to 0.1% by weight, and even more preferably 0.0001 to 0.07% by weight, 0.0001 to 0.04% by weight, or 0.0001 to 0.01% by weight. In particular, when a quaternary ammonium salt is used as the preservative, the content of the quaternary ammonium salt is, from the above-mentioned viewpoint, preferably 0.0001 to 0.1 wt %, more preferably 0.0001 to 0.07 wt %, even more preferably 0.0001 to 0.04 wt %, and even more preferably 0.0001 to 0.01 wt %. When parahydroxybenzoic acid is used as the preservative, the content of parahydroxybenzoic acid is, from the above-mentioned viewpoint, preferably 0.0001 to 0.3 wt %, more preferably 0.0001 to 0.1 wt %, and even more preferably 0.0001 to 0.07 wt %.
[0018] Because the nasal irrigation composition of the present invention has an excellent effect of alleviating irritation to the nasal mucosa, even if the amount of preservative is relatively large, the effect of alleviating irritation to the nasal mucosa can be effectively achieved. From this viewpoint, a preferred total content of component (A) is, for example, 0.003 to 0.6 wt %, 0.005 to 0.6 wt %, 0.01 to 0.6 wt %, or 0.04 to 0.6 wt %. In particular, when a quaternary ammonium salt is used as the preservative, a preferred content of the quaternary ammonium salt is, from the above viewpoint, preferably 0.003 to 0.6 wt %, more preferably 0.005 to 0.6 wt %. When parahydroxybenzoic acid is used as the preservative, a preferred content of the parahydroxybenzoic acid is, from the above viewpoint, preferably 0.01 to 0.6 wt %, more preferably 0.04 to 0.6 wt %.
[0019] When the nasal cleansing composition of the present invention is used as is without dilution before use, the content of component (A) in the nasal cleansing composition of the present invention is the same as the concentration of the preservative at the time of use described above. When the nasal cleansing composition of the present invention is diluted before use, the content of component (A) in the nasal cleansing composition of the present invention is the amount obtained by multiplying the concentration of the preservative at the time of use described above by the dilution factor. The same applies to the contents of components other than component (A) described below.
[0020] (B) Sodium bicarbonate The nasal cleansing composition of the present invention contains sodium bicarbonate as component (B). Sodium bicarbonate enhances the antibacterial activity of component (A). In addition to enhancing the antibacterial activity, sodium bicarbonate can also have other effects, such as reducing the viscosity of nasal discharge when used for cleansing the upper respiratory tract mucosa, particularly nasal irritation, and / or reducing irritation when used for mucosal cleansing.
[0021] The content of component (B) in the nasal cleansing composition of the present invention is not particularly limited, but may be, for example, 0.3 to 2.0 wt %, more preferably 0.5 to 1.5 wt %, even more preferably 0.7 to 1.3 wt %, and even more preferably 0.8 to 1.2 wt %.
[0022] The ratio of component (A) to component (B) in the nasal cleansing composition of the present invention is determined based on the content of each of the above components, but the content of component (B) per part by weight of component (A) is preferably 10 to 250 parts by weight, preferably 13 to 200 parts by weight, more preferably 15 to 170 parts by weight, and even more preferably 18 to 150 parts by weight. In particular, when a quaternary ammonium salt is used as component (A), the content of component (B) per part by weight of component (A) is 10 to 250 parts by weight, preferably 50 to 200 parts by weight, more preferably 100 to 170 parts by weight, and even more preferably 130 to 150 parts by weight. In particular, when a parahydroxybenzoate ester is used as component (A), the content of component (B) per part by weight of component (A) is 10 to 40 parts by weight, preferably 13 to 30 parts by weight, more preferably 15 to 25 parts by weight, and even more preferably 18 to 22 parts by weight.
[0023] (C) Mint-Based Flavor The nasal cleansing composition of the present invention contains a mint-based flavor as component (C). The mint-based flavor reduces the irritation of the nasal mucosa caused by the nasal cleansing composition containing components (A) and (B).
[0024] Mint fragrances are aromatic compounds derived from the leaves of Mentha L. plants in the Lamiaceae family. Component (C) can be blended in the form of essential oils extracted from the leaves of these plants. Specific examples of these plants include spearmint, English mint, Kentucky kernel mint, peppermint, candy mint, Swiss licorice mint, curly mint, rococo mint, cool mint, pennyroyal mint, apple mint, pineapple mint, Bowles mint, lemon mint, eau de cologne mint, lavender mint, grapefruit mint, and orange mint. As component (C), one essential oil from these plants may be used alone, or multiple essential oils may be used in combination.
[0025] Among the above plants, from the viewpoint of further enhancing the effect of alleviating irritation to the nasal mucosa, preferred are essential oils of peppermint, candy mint, Swiss licorice mint, curly mint, rococo mint, and cool mint, and more preferred is peppermint essential oil (peppermint oil).
[0026] Specific compounds contained in mint-based fragrances include monoterpenes, preferably cyclic monoterpenes, and more preferably carvone, menthofuran, menthol, menthone, isomenthone, menthyl acetate, pulegone, lotundiphorone, etc. Component (C) may contain any of these compounds alone or in combination.
[0027] Among these compounds, from the viewpoint of further enhancing the effect of alleviating irritation to the nasal mucosa, preferred are menthol, menthofuran, menthyl acetate, isomenthone, and carvone, and more preferred are menthol, menthofuran, and menthyl acetate.
[0028] The content of component (C) in the nasal cleansing composition of the present invention may be appropriately set depending on the degree of effect of alleviating irritation to the nasal mucosa that is to be obtained, and may be, for example, 0.0001 to 0.01% by weight. From the viewpoint of further enhancing the effect of alleviating irritation to the nasal mucosa, the content is preferably 0.001 to 0.01% by weight, more preferably 0.002 to 0.01% by weight, more preferably 0.0025 to 0.01% by weight, 0.0025 to 0.008% by weight, or 0.0025 to 0.005% by weight.
[0029] Furthermore, the content ratio of component (A) to component (C) in the nasal cleansing composition of the present invention is determined based on the content of each of the above components, but preferably, the content of component (C) per 1 part by weight of component (A) is, for example, 0.01 to 2 parts by weight, preferably 0.03 to 2 parts by weight, more preferably 0.045 to 2 parts by weight, even more preferably 0.05 to 2 parts by weight, 0.05 to 1.2 parts by weight, 0.05 to 0.8 parts by weight, or 0.05 to 0.6 parts by weight. In particular, when a quaternary ammonium salt is used as the component (A), the amount of component (C) per 1 part by weight of the component (A) is, for example, 0.1 to 2 parts by weight, preferably 0.3 to 2 parts by weight, more preferably 0.35 to 2 parts by weight, even more preferably 0.4 to 2 parts by weight, 0.4 to 1.2 parts by weight, 0.4 to 0.8 parts by weight, or 0.4 to 0.6 parts by weight. When a parahydroxybenzoic acid ester is used as the component (A), the amount of component (C) per 1 part by weight of the component (A) is, for example, 0.03 to 0.2 parts by weight, more preferably 0.045 to 0.2 parts by weight, even more preferably 0.05 to 0.2 parts by weight, 0.05 to 0.12 parts by weight, 0.05 to 0.1 parts by weight, or 0.05 to 0.08 parts by weight.
[0030] When the nasal cleansing composition of the present invention contains menthol, menthofuran, and menthyl acetate as component (C), the total content of menthol, menthofuran, and menthyl acetate is, for example, 0.0001 to 0.008 wt %, and from the viewpoint of further enhancing the effect of alleviating irritation to the nasal mucosa, is preferably 0.0005 to 0.008 wt %, more preferably 0.0015 to 0.008 wt %, even more preferably 0.002 to 0.008 wt %, 0.002 to 0.006 wt %, or 0.002 to 0.004 wt %.
[0031] When the nasal cleansing composition of the present invention contains menthol, menthofuran, and menthyl acetate as component (C), the ratio of the content of component (A) in the nasal cleansing composition of the present invention to the total amount of menthol, menthofuran, and menthyl acetate is determined based on the content of each of the above components, and preferably, the total amount of menthol, menthofuran, and menthyl acetate per part by weight of component (A) is, for example, 0.008 to 1.8 parts by weight, preferably 0.024 to 1.8 parts by weight, more preferably 0.036 to 1.8 parts by weight, even more preferably 0.04 to 1.8 parts by weight, 0.04 to 1.1 parts by weight, 0.04 to 0.75 parts by weight, or 0.04 to 0.55 parts by weight. In particular, when a quaternary ammonium salt is used as the component (A), the total amount of menthol, menthofuran, and menthyl acetate per 1 part by weight of the component (A) is, for example, 0.08 to 1.8 parts by weight, preferably 0.24 to 1.8 parts by weight, more preferably 0.3 to 1.8 parts by weight, even more preferably 0.33 to 1.8 parts by weight, 0.33 to 1.1 parts by weight, 0.33 to 0.75 parts by weight, or 0.33 to 0.55 parts by weight. When a parahydroxybenzoic acid ester is used as the component (A), the total amount is, for example, 0.024 to 0.18 parts by weight, more preferably 0.036 to 0.18 parts by weight, even more preferably 0.04 to 0.18 parts by weight, 0.04 to 0.11 parts by weight, 0.04 to 0.09 parts by weight, or 0.04 to 0.075 parts by weight.
[0032] (D) Nonionic Surfactant The nasal cleansing composition of the present invention may contain a nonionic surfactant as component (D).
[0033] The nonionic surfactant used in the present invention is not particularly limited as long as it is applicable to the nasal cavity, and examples thereof include polyoxyethylene sorbitan fatty acid esters, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid esters, polyoxyethylene alkyl ethers, polyoxyethylene glycerin fatty acid esters, polyoxyethylene sorbitol fatty acid esters, glycerin fatty acid esters, sucrose fatty acid esters, etc. These nonionic surfactants may be used alone or in combination of two or more.
[0034] Among these nonionic surfactants, polyoxyethylene sorbitan fatty acid esters and polyoxyethylene hydrogenated castor oil are preferred from the viewpoint of more effectively alleviating irritation to the nasal mucosa.
[0035] The average number of moles of ethylene oxide (EO) added that constitutes the polyoxyethylene sorbitan fatty acid ester is not particularly limited, but may be, for example, 5 to 40 moles, preferably 10 to 30 moles, and more preferably 15 to 25 moles. The number of carbon atoms in the fatty acid that constitutes the polyoxyethylene sorbitan fatty acid ester is not particularly limited, but may be, for example, 10 to 22, preferably 14 to 22, and more preferably 16 to 20. Specific examples of polyoxyethylene sorbitan fatty acid esters include polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan trioleate, polyoxyethylene sorbitan tristearate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monopalmitate, and polyoxyethylene sorbitan monolaurate. Among these polyoxyethylene sorbitan fatty acid esters, preferred are polyoxyethylene sorbitan monooleate (polysorbate 80) having an average number of moles of ethylene oxide (EO) added of 20, and polyoxyethylene sorbitan monostearate (polysorbate 60) having an average number of moles of ethylene oxide (EO) added of 20.
[0036] The average number of moles of ethylene oxide (EO) added in polyoxyethylene hydrogenated castor oil is not particularly limited, but may be, for example, 5 to 100 moles, preferably 20 to 80 moles, and more preferably 40 to 80 moles. Among these, polyoxyethylene hydrogenated castor oil 60 and polyoxyethylene hydrogenated castor oil 80 are preferred.
[0037] The content of component (D) in the nasal cleansing composition of the present invention is, for example, 0.001 to 0.5 wt %, preferably 0.01 to 0.3 wt %, more preferably 0.02 to 0.1 wt %, and even more preferably 0.04 to 0.08 wt %.
[0038] The content ratio of component (A) to component (D) in the nasal cleansing composition of the present invention is determined based on the content of each of the above components, but preferably, the content of component (D) per 1 part by weight of component (A) is, for example, 0.1 to 30 parts by weight, preferably 0.5 to 20 parts by weight, more preferably 1 to 10 parts by weight.
[0039] Other Components In addition to the above-described components, the nasal cleansing composition of the present invention may contain other bases and additives required for formulation, etc., as long as the effects of the present invention are not impaired. Such bases and additives are not particularly limited as long as they are pharmaceutically acceptable, and examples thereof include water, monohydric lower alcohols having 1 to 5 carbon atoms, polyhydric alcohols, surfactants other than component (D), colorants, thickeners, pH adjusters, humectants, isotonicity agents, stabilizers, antioxidants, UV absorbers, buffers, solubilizers, solubilizing agents, chelating agents, and fragrances other than component (C). These bases and additives may be used alone or in combination of two or more.
[0040] In addition to the above-mentioned components, the nasal cleansing composition of the present invention may contain other pharmacological ingredients as needed, provided that the effects of the present invention are not impaired. Examples of such pharmacological ingredients include vitamins, amino acids, antihistamines, antiallergic agents, local anesthetics, anti-inflammatory agents, blood circulation promoting ingredients, astringents, cooling agents, mucopolysaccharides, etc. These pharmacological ingredients may be used alone or in combination of two or more.
[0041] Dosage Form, Use, and Product Form The dosage form of the nasal cleansing composition of the present invention is not particularly limited, and examples thereof include powders, granules, tablets, and liquids. Among these, liquids are preferred because the nasal cleansing composition can be used as is or can be easily diluted when used. Nasal cleansing compositions in these dosage forms can be prepared by commonly known methods.
[0042] The nasal irrigation composition of the present invention may be prepared so that it can be used as is without dilution when used, or it may be prepared so that it can be diluted when used. Here, dilution includes both dissolving a powder, granules, or tablet in a liquid base, and mixing a liquid (i.e., a concentrated liquid) with a liquid base.
[0043] When the nasal irrigation composition of the present invention is prepared so as to be diluted before use, the dilution ratio at the time of use is not particularly limited, but in the case of a concentrated liquid preparation, it may be, for example, 2 to 10 times, preferably 3 to 8 times, more preferably 4 to 6 times. Furthermore, the liquid base used for dilution is preferably water.
[0044] The nasal cleansing composition of the present invention is used for cleaning the inside of the nasal cavity. Examples of methods for cleaning the inside of the nasal cavity using the nasal cleansing composition of the present invention include a method of introducing the nasal cleansing composition of the present invention into one of the nostrils and letting it flow out from the nasal cavity as is; a method of introducing the nasal cleansing composition of the present invention into the nasal cavity and letting it flow out through the mouth; and a method of introducing the nasal cleansing composition of the present invention into one of the nostrils and letting it flow out from the other nasal cavity. When introducing the nasal cleansing composition of the present invention into the nasal cavity, it may be introduced in the form of droplets (particularly, a mist) or as a liquid stream.
[0045] The nasal cleansing composition of the present invention is used by being contained in a container that can discharge the contents into the nasal cavity. The container may be a container that can discharge the contents in the form of droplets by dripping or spraying, or a container that can discharge the contents as a liquid stream. A suitable example of a container that can store the nasal cleansing composition of the present invention is a container for nasal drops, i.e., a container that can discharge the contents in the form of droplets into the nasal cavity by dripping or spraying.
[0046] The present invention will be explained in more detail below by showing examples, but the present invention is not limited to these examples.
[0047] Test Example: Nasal cleansing compositions (liquids) were prepared with the compositions shown in Tables 1 and 2. The peppermint oil contained a total of 85.5 parts by weight of menthol, menthofuran, and menthyl acetate per 100 parts by weight of the peppermint oil. The resulting nasal cleansing compositions were evaluated for their level of irritation to the nasal mucosa. Specifically, the nasal cleansing compositions were first placed in a container capable of spraying the composition as a mist into the nasal cavity (a commonly used nasal drop container). Next, 10 subjects sprayed approximately 0.15 ml of the nasal cleansing composition as a mist into one nostril to clean the nasal cavity, and the level of irritation during nasal cleansing was evaluated. The degree of irritation during nasal irritation was assessed by a questionnaire using the VAS (Visual Analogue Scale) method, with "no irritation" being scored as 0 and "strong irritation" being scored as 100. The average of the questionnaire results from 10 subjects was calculated and rounded to the nearest whole number. Furthermore, the irritation improvement rate (%), which indicates the degree of relief of irritation to the nasal mucosa, was calculated based on the following formula. In the formula, the reference VAS average value refers to the average VAS value of the nasal irritation composition of Comparative Example 1 or Comparative Example 4 in each table. The results are shown in Table 1.
[0048]
[0049]
[0050]
[0051] As shown in Tables 1 and 2, in nasal irrigation compositions containing a preservative and sodium bicarbonate, when a non-mint-based fragrance was added, almost no reduction in irritation during nasal irrigation was observed (Comparative Examples 2, 3, 5, and 6), but when a mint-based fragrance was added, the irritation during nasal irrigation was significantly reduced (Examples 1 to 4).
Claims
1. A nasal irrigation composition containing (A) a preservative, (B) sodium bicarbonate, and (C) a mint-based flavoring.
2. A nasal cleansing composition according to claim 1, wherein component (A) is a quaternary ammonium and / or a parahydroxybenzoic acid ester.
3. The nasal irrigation composition according to claim 1, wherein component (C) comprises peppermint oil.
4. A nasal cleansing composition according to claim 1, wherein the content of component (C) is 0.005 to 0.3% by weight.
5. A nasal cleansing composition according to claim 1, wherein the component (C) is contained in an amount of 0.005 to 1 part by weight per 1 part by weight of the component (A).
6. A nasal cleansing composition according to claim 1, further comprising (D) a nonionic surfactant.
